Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA289883
Max Phase: Preclinical
Molecular Formula: C40H50N2O9
Molecular Weight: 702.84
Molecule Type: Small molecule
Associated Items:
ID: ALA289883
Max Phase: Preclinical
Molecular Formula: C40H50N2O9
Molecular Weight: 702.84
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCCCC(=O)Nc1ccc(C(=O)Nc2cc(C(=O)O)ccc2Oc2cc(C(=O)O)cc(C(=O)O)c2)cc1
Standard InChI: InChI=1S/C40H50N2O9/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-36(43)41-32-21-18-28(19-22-32)37(44)42-34-27-29(38(45)46)20-23-35(34)51-33-25-30(39(47)48)24-31(26-33)40(49)50/h18-27H,2-17H2,1H3,(H,41,43)(H,42,44)(H,45,46)(H,47,48)(H,49,50)
Standard InChI Key: RJDPPFGDOQJPLN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 702.84 | Molecular Weight (Monoisotopic): 702.3516 | AlogP: 10.03 | #Rotatable Bonds: 24 |
Polar Surface Area: 179.33 | Molecular Species: ACID | HBA: 6 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.24 | CX Basic pKa: | CX LogP: 10.14 | CX LogD: 0.54 |
Aromatic Rings: 3 | Heavy Atoms: 51 | QED Weighted: 0.06 | Np Likeness Score: -0.57 |
1. Hiramatsu Y, Tsukida T, Nakai Y, Inoue Y, Kondo H.. (2000) Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model., 43 (8): [PMID:10780903] [10.1021/jm990342j] |
Source(1):